HOUSE OF REPRESENTATIVES

THE THIRTIETH LEGISLATURE

REGULAR SESSION OF 2020

 

COMMITTEE ON HEALTH

Rep. John M. Mizuno, Chair

Rep. Bertrand Kobayashi, Vice Chair

 

Rep. Della Au Belatti

Rep. Calvin K.Y. Say

Rep. Nadine K. Nakamura

Rep. James Kunane Tokioka

Rep. Joy A. San Buenaventura

Rep. Gene Ward

 

NOTICE OF HEARING

 

DATE:

Thursday, March 12, 2020

TIME:

9:00 a.m.

PLACE:

Capitol Auditorium

State Capitol

415 South Beretania Street

 

A G E N D A

 

SB 31, SD3

(SSCR3288)

Status

RELATING TO HEALTH.

Amends the definition of "preceptor" and "volunteer-based supervised clinical training rotation" to improve accessibility for providers to receive income tax credits for acting as preceptors.  Revises the membership of the Preceptor Credit Assurance Committee to include the Director of Health.  Effective 7/1/2050.  (SD3)

 

HLT, CPC, FIN

SB 2281, SD1

(SSCR2901)

Status

RELATING TO BEHAVIOR ANALYSTS.

Makes permanent the regulation of behavior analysts.  Exempts behavior analysts licensing program from auditor evaluation requirement.  (SD1)

 

HLT, CPC, FIN

SB 2278, SD2

(SSCR3146)

Status

RELATING TO HEALTH INSURANCE.

Prohibits nonparticipating health care providers from balance billing patients in specific circumstances.  Establishes rate calculation requirements for reimbursement of nonparticipating providers.  Repeals January 2, 2025.  Effective 1/2/2050.  (SD2)

 

HLT, CPC, FIN

SB 2423, SD1

(SSCR2943)

Status

RELATING TO MEDICAL SERVICE BILLING.

Establishes billing requirements for unanticipated medical billing and unanticipated coverage gaps of patients for out-of-network emergency services received from non-participating providers.  Requires the Insurance Commissioner to refer certain disputes between insurers and non-participating providers to an independent dispute resolution entity for binding arbitration.  Effective 1/1/2021.  (SD1)

 

HLT, CPC, FIN

SB 2429, SD2

(SSCR3374)

Status

RELATING TO HEALTH.

Extends the state-funded medical assistance provided to pregnant women for up to 1 year post-pregnancy in certain circumstances.  Effective 7/1/2050.  (SD2)

 

HLT, CPC, FIN

SB 2439, SD1

(SSCR2940)

Status

RELATING TO HEALTH INSURANCE.

Requires insurers, mutual benefit societies, and health maintenance organizations to provide coverage for the cost of auto-injectable epinephrine based on appropriate weight-based dosage for insured persons eighteen years of age or younger, beginning 1/1/2021.  (SD1)

 

HLT, CPC, FIN

SB 2586, SD1

(SSCR3175)

Status

RELATING TO MEDICAL CANNABIS.

Permits qualifying patients to be reimbursed by health insurers, mutual benefit societies, and health maintenance organizations for amounts spent on medical cannabis and manufactured cannabis products.  Limits the monthly amount of reimbursement.  Effective 7/1/2050.  (SD1)

 

HLT, CPC/JUD, FIN

SB 2787, SD1

(SSCR3139)

Status

RELATING TO MEDICAL CANNABIS.

Authorizes the department of health to issue permits to medical cannabis dispensaries for the delivery of medical cannabis and manufactured cannabis products to qualifying patients or primary caregivers if certain conditions are met.  Authorizes the department of health to issue medical cannabis transporter licenses in specific situations.  (SD1)

 

HLT, CPC/JUD, FIN

SB 2637, SD2

(SSCR3377)

Status

RELATING TO CHILDREN'S HEALTH.

Requires the Department of Health to establish, implement, and evaluate a statewide program for early identification of, and intervention for, lead poisoning in infants.  Requires insurers to provide coverage for the testing.  Effective 7/1/2050.  (SD2)

 

HLT, CPC, FIN

SB 2724

(SSCR2906)

Status

RELATING TO LEAD-BASED PAINT.

Prohibits the use of lead-based paint on outdoor structures after 12/31/21.

 

HLT, CPC, JUD

SB 2917, SD1

(SSCR3264)

Status

RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM.

Updates section 329-104(c), Hawaii Revised Statutes, to clarify who may access information stored in the electronic prescription accountability system.  (SD1)

 

HLT, CPC/JUD, FIN

SB 2919, SD1

(SSCR3248)

Status

RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM.

Requires that the dispensing of a pharmacist-prescribed opioid antagonist be reported to the State's electronic prescription accountability system.  (SD1)

 

HLT, CPC/JUD, FIN

SB 3091, SD1

(SSCR3042)

Status

RELATING TO EMERGENCY MEDICAL SERVICES.

Enables the Hawaii medical board to certify emergency medical responders other than emergency ambulance personnel.  Effective 7/1/2050.  (SD1)

 

HLT, CPC, FIN

SB 2284, SD1

(SSCR3134)

Status

RELATING TO HEALTH CARE INSURANCE.

Prohibits a health care insurer, mutual benefit society, or health maintenance organization from requiring an insured, subscriber, member, or enrollee diagnosed with stage two through stage four cancer to undergo step therapy prior to covering the insured for the drug prescribed by the insured's health care provider, under certain conditions, for health insurance policies and contracts issued or renewed after 12/31/2020.  (SD1)

 

HLT, CPC, FIN

 

 

DECISION MAKING TO FOLLOW

 

 

Persons wishing to offer comments should submit testimony at least 24 hours prior to the hearing.  Testimony should indicate:

·    Testifier's name with position/title and organization;

·    The Committee(s) to which the comments are directed;

·    The date and time of the hearing; and

·    Measure number. 

 

While every effort will be made to incorporate all testimony received, materials received on the day of the hearing or improperly identified or directed, may be distributed to the Committee after the hearing.

 

Submit testimony in ONE of the following ways:

PAPER: 10 copies (including an original) to Room 403 in the State Capitol;

FAX:     For testimony less than 5 pages in length, transmit to 808-586-6311 (Oahu) or 1-800-535-3859 (for Neighbor Islander without a computer to submit testimony through e-mail or the Web); or

WEB:    For testimony less than 20MB in size, transmit from http://www.capitol.hawaii.gov/submittestimony.aspx.

 

Testimony submitted will be placed on the legislative website.  This public posting of testimony on the website should be considered when including personal information in your testimony.

 

If you require special assistance or auxiliary aids and/or services to participate in the House public hearing process (i.e., sign or foreign language interpreter or wheelchair accessibility), please contact the Committee Clerk at 586-6050 or email your request for an interpreter to [email protected] at least 24 hours prior to the hearing for arrangements.  Prompt requests submitted help to ensure the availability of qualified individuals and appropriate accommodations.

 

 

 

 

 

 

________________________________________

Rep. John M. Mizuno

Chair